Einträge von Amend, Pablo auf dem Publikationsserver

Pavel, Vlad , Amend, Pablo, Schmidtner, Niklas, Utrata, Alexander, Birner, Charlotte, Schmid, Stephan , Krautbauer, Sabrina, Müller, Martina, Mester, Patricia und Buechler, Christa (2024) Chemerin Levels in COVID-19 Are More Affected by Underlying Diseases than by the Virus Infection Itself. Biomedicines 12 (9), S. 2099.

Mester, Patricia, Amend, Pablo, Schmid, Stephan , Wenzel, Jürgen J. , Höring, Marcus , Liebisch, Gerhard , Krautbauer, Sabrina, Müller, Martina, Buechler, Christa und Pavel, Vlad (2024) Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels. Infectious Disease Reports 16 (4), S. 593-607.

Pavel, Vlad , Räth, Ulrich, Schmid, Stephan , Krautbauer, Sabrina, Keller, Dennis, Amend, Pablo, Müller, Martina, Mester, Patricia und Buechler, Christa (2024) Serum Adiponectin Predicts COVID-19 Severity. Biomedicines 12 (5), S. 1043.

Mester, Patricia, Räth, Ulrich, Schmid, Stephan , Amend, Pablo, Keller, Dennis, Krautbauer, Sabrina, Bondarenko, Sofiia, Müller, Martina, Buechler, Christa und Pavel, Vlad (2024) Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity. Biomedicines 12 (1), S. 125.

Mester, Patricia, Amend, Pablo, Schmid, Stephan , Müller, Martina, Buechler, Christa und Pavel, Vlad (2023) Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19. Viruses 15 (7), S. 1511.

Amend, Pablo, Mester, Patricia, Schmid, Stephan , Müller, Martina, Buechler, Christa und Pavel, Vlad (2023) Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive Infections. Biomedicines 11 (7), S. 1779.